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Abstract
Post-transcriptional regulation of mRNA by the RNA binding protein HuR (Elavl1) is required in 
B cells for the germinal centre reaction and for the production of class-switched antibodies in 
response to T-independent antigens. Transcriptome-wide examination of RNA isoforms, 
abundance and translation in HuR-deficient B cells, together with direct measurements of HuR-
RNA interaction, revealed that HuR-dependent mRNA splicing affects hundreds of transcripts 
including the dihydrolipoamide S-succinyltransferase (Dlst), a subunit of the 2-oxoglutarate 
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dehydrogenase complex (αKGDH). In the absence of HuR, defective mitochondrial metabolism 
results in high amounts of reactive oxygen species and B cell death. Our study shows how post-
transcriptional processes control the balance of energy metabolism required for B cell proliferation 
and differentiation.
The generation of antibodies is a hallmark of the fight against infection and is a principal 
goal in the design of vaccines. B lymphocytes produce distinct antibody isotypes by the 
process of class switch recombination (CSR). Antibodies arising from extrafollicular 
differentiation of B cells into antibody-secreting cells (ASC) can prevent pathogen spread at 
early stages of infection, while switched antibodies quickly recruit effector cells during 
memory responses. Somatic hypermutation (SHM) of the immunoglobulin genes increases 
antibody affinity. This requires the positive selection of B cells, bearing high-affinity 
membrane immunoglobulins and by T cells within germinal centers (GC), the specific 
anatomical structures formed in peripheral lymphoid organs during many immune 
responses.
Resting lymphocytes require glucose and glycolysis to survive, but undergo metabolic 
reprogramming following antigen encounter to meet the energetic and biosynthetic demands 
of proliferation1. Unlike T cells, which disproportionately increase glycolysis when 
activated, B cell activation through membrane immunoglobulin is accompanied by a 
balanced increase in both glycolysis and oxidative phosphorylation2, 3. The molecular 
mechanisms which control this metabolic reprogramming in lymphocytes have come under 
intense scrutiny in recent years and have highlighted a link between metabolic flux and cell 
fate decisions1.
The network of transcription factors required for B cell activation and subsequent 
differentiation has been elucidated in some detail4, 5. By contrast, despite the established 
role of splicing and polyadenylation in the control of immunoglobulin gene expression, 
relatively little is known about how post-transcriptional regulation of gene expression 
influences the outcome of antigen encounter in B cells. Post-transcriptional fate of mRNA is 
mediated by its associated RNA-binding proteins (RBP) and non-coding RNAs, which 
determine the timing and magnitude of protein expression6, 7. B cell specific deletion of the 
RNA-processing enzyme Dicer inhibits the GC reaction8. Moreover, individual microRNAs, 
like miR-155, are regulators of ASC and GC formation9-11. Less is known about the 
importance of RBPs. Roquin is required for the restraint of helper T cell function during the 
GC reaction, but plays a minor role in B cells12. The RBP HNRPD has been implicated in B 
cell survival13, but essential functions for sequence specific RBPs have not yet been found 
in B cells.
HuR (gene name Elavl1) is an RBP implicated in both nuclear and cytoplasmic regulation of 
RNA fate. HuR binds to uridine (U)-tracts present mostly within introns and 3′UTRs, which 
correlates with its function as regulator of mRNA splicing and stability14, 15. HuR null mice 
are embryonic lethal16. Conditional HuR knockout (HuR cKO) mice have proven a useful 
tool to understand the role of HuR in myeloid cells where it limits proinflammatory cytokine 
production during chronic inflammation and cancer17, 18. HuR is required for maintenance 
of haematopoietic stem cells19, and the selection and chemotaxis of T cells20.
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Here, we show that regulation of the B cell transcriptome by HuR is essential for normal 
antibody responses. B cell-specific deletion of HuR reveals an obligate role for HuR in the 
GC reaction. Moreover, the production of class-switched antibodies induced by T-
independent antigens is dependent upon HuR. To identify the direct targets of HuR action, 
we mapped HuR:RNA interactions at single nucleotide level resolution in primary B 
cells21, 22. Integration of gene expression profiling using RNAseq and identification of 
translationally regulated mRNA by ribosome profiling established a direct correlation 
between changes in gene expression and translation of specific mRNAs bound by HuR. Our 
analysis indicates that HuR regulates the expression of genes related to B cell energy 
metabolism and prevents the accumulation of fatal levels of reactive oxygen species upon B 
cell activation.
RESULTS
HuR expression is increased upon B cell activation
HuR is the only member of the Elavl family expressed in splenic B cells (Fig. 1a). In order 
to understand the role of HuR during B cell development and activation we generated B cell-
specific conditional KO mice (Elavl1fl/fl Mb1-Cre, hereafter HuR-cKO mice). Analysis of 
HuR protein expression by flow cytometry showed that it was deleted from the pro-B cell 
stage in the bone marrow (BM) and was undetectable in transitional and mature B 
lymphocytes (Fig. 1b-d). HuR was similarly expressed in all B cell populations present in 
the spleen. RT-qPCR analysis of GC B cells, formed in the spleen after immunisation, 
showed a 6-fold increase in HuR mRNA in GC B cells compared to non-GC B cells (Fig. 
1e). Intracellular flow cytometry indicated that HuR protein was increased by 2-fold in GC 
B cells (Fig. 1f). B cell activation with LPS or αCD40 + IL-4 + IL-5 increased HuR protein 
expression by up to 3-fold (Fig. 1g). Taken together, these data suggest that HuR expression 
is increased during B cell activation in vitro and in vivo.
B cell development following HuR deletion in pro-B cells
Normal proportions of B cell subpopulations were present in BM, spleen and lymph nodes 
of HuR-cKO mice (Fig. 2a-c). We found a small decrease in the number of pre-B cells in 
BM and in the number of transitional and FO B cells in spleens of HuR-cKO mice. HuR-
cKO mice had reduced numbers of B1 B cells in the peritoneal cavity (Fig. 2d). Analysis of 
the incorporation of 2-bromodeoxyuridine (BrdU) into the DNA of rapidly proliferating pre-
B cells was not different in HuR-cKO mice (Fig. 2e and Supplementary Fig. 1a and 1b). 
Furthermore, B cell turnover in the spleen, inferred from BrdU incorporation over a 7-day 
period, was not different from control mice (Fig. 2f). Thus, with the exception of B1 B cells, 
there is little requirement for HuR for either B cell development or homeostasis.
B cells require HuR for normal antibody responses
HuR-cKO mice showed a significant reduction in all immunoglobulin (Ig) isotypes present 
in serum, apart from IgA (Fig. 3a). IgG1 and IgG2b titers were reduced by 2.5-fold in HuR-
cKO mice, whereas IgG3 and IgM titers were reduced by 6- and 12-fold, respectively. 
Decreased IgM titers could result from the reduction of B1 B cells, as these contribute 
substantially to serum IgM. The biggest difference was found in IgG2c titers that were 
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reduced by 200-fold in HuR-cKO mice. The decrease in almost all antibody isotypes likely 
reflects a requirement for HuR in B cells for a functional response following antigen 
encounter.
To investigate the requirement for HuR during the response of B cells to antigen, we 
immunised HuR-cKO mice with the thymus (T)-independent antigens, Ficoll or LPS 
coupled to the hapten 4-hydroxy-3 nitrophenolic acid (NP). NP-reactive IgM titers in serum 
showed a 5-fold reduction with both antigens (Fig. 3b and 3c). By contrast, we were unable 
to detect NP-reactive IgG3 antibodies in serum from HuR-cKO mice. Next, we evaluated the 
ability of HuR-cKO B cells to participate in a thymus-dependent antibody response by 
assessing the serum antibody responses following primary and secondary immunisation with 
NP coupled to keyhole limpet haemocyanin (KLH) (Fig. 3d). Serum NP-reactive IgM titers 
showed an average 8.5-fold reduction. NP23-reactive IgG1 titers, which reflect the 
combination of both low and high affinity antibodies, were 15-times lower in HuR-cKO 
mice than in control mice. Memory responses evaluated seven days after secondary 
immunisation were clearly detectable in HuR-cKO mice in the form of IgM antibodies. By 
contrast, NP2-reactive IgG1 titers did not increase, suggesting high affinity IgG1 memory 
cells did not form, or, if they did, their reactivation failed to generate ASC. As a measure of 
affinity maturation, we determined the ratio of NP2- and NP23-reactive IgG1 antibodies, 
which indicated that NP-reactive antibodies in HuR-cKO mice failed to undergo affinity 
maturation (Fig 3e).
Affinity maturation takes place in GC, where helper T cells select B cells with the highest 
affinity for antigen. GC formation after seven days of immunisation with NP-KLH was 
diminished in HuR-cKO mice. The number of GC B cells was reduced by more than 6-fold 
(Fig. 3f). Similarly, following administration of highly immunogenic sheep red blood cells 
the GC response was defective over time in HuR-cKO mice (Supplementary Fig. 1c and 1d). 
Consistent with reduced titers of serum antibodies, the number of NP-reactive IgM ASC in 
the spleen of HuR-cKO mice immunised with NP-KLH was reduced by 2-fold, whereas the 
number of NP-reactive IgG1 ASC was reduced by 50-fold (Fig. 3g). A similar reduction was 
found in the number of NP-reactive IgM and IgG1 ASC in the spleen of HuR-cKO mice 
seven days after secondary immunisation with NP-KLH (Fig. 3h). Further analysis of ASC 
in the BM showed that HuR-cKO mice contained a similar number of NP-reactive IgM 
ASC, but NP-reactive IgG1 ASC were barely detectable (>100-fold reduction) when 
compared to control mice (Fig. 3i). These data show that HuR is required for proper B cell 
activation and/or differentiation following antigen encounter.
Regulation of the B cell transcriptome by HuR
To examine whether an early stage of B cell activation was affected by the absence of HuR, 
we measured changes in intracellular Ca2+ following crosslinking of cell surface IgM. The 
Ca2+ flux elicited after activation of Mb1-Cre unfloxed controls (defined as “Ctrl.”) and 
HuR-cKO LN B cells was similar using either a highly crosslinking anti-IgM F(ab’)2 or a 
monoclonal anti-IgM (mAb B7.6) (Supplementary Fig. 2a). Additionally, cell surface 
expression of CD25, CD40, CD69 and CD86 was increased to a similar extent in response to 
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a variety of stimuli (Supplementary Fig. 2b and 2c), indicating that, by these criteria at least, 
B cell activation was normal in the absence of HuR.
To discover the molecular mechanisms regulated by HuR in resting and activated B cells, 
we performed an integrated analysis of three high throughput measurements of the B cell 
transcriptome. Firstly, we searched for differential mRNA expression in HuR-cKO B cells 
by mRNAseq. Secondly, we determined the differences in mRNA translation between HuR-
cKO and control B cells using ribosome footprinting (Ribo-Seq). Thirdly, we characterised 
HuR-RNA interactions at the single nucleotide level in LPS-activated B cells using iCLIP. 
Taken together, these measurements have the power to discriminate between changes in 
RNA isoform and abundance as well as translational regulation, and can relate these changes 
to HuR binding. Thus detected changes can be ascribed to be direct or indirect effects of 
HuR:RNA interactions. None of the changes were due to compensatory regulatory 
mechanisms affecting the abundance or ribosome loading of mRNAs encoding other 
members of the Elavl-family or of other AU-rich element binding proteins (Supplementary 
Fig. 3).
Differential expression analysis of mRNAseq and Ribo-Seq followed by pathway 
enrichment analysis indicated gene signatures related to different aspects of the cell cycle 
and energy metabolism were enriched in HuR-cKO B cells (Table 1). HuR deficiency 
influenced expression of genes related to glycolysis, TCA cycle and oxidative 
phosphorylation, three pathways increased in GC B cells and after B cell activation with 
LPS (Supplementary Fig. 4a, 4b and 4c). Blockade of these energy pathways using 2-
deoxyglucose (2DG), CPI-613 or Oligomycin A decreased B cell survival, cell growth and 
cell proliferation after mitogen stimulation (Supplementary Fig. 4d and 4e). Analysis of the 
global fold-change in mRNA expression and translation of genes related to glycolysis, TCA 
cycle and oxidative phosphorylation showed no change when comparing ex vivo 
(unstimulated) control versus HuR-cKO B cells. By contrast, global expression and/or 
translation of these mRNAs were increased in LPS-activated HuR-cKO B cells, suggesting 
that HuR is only important for regulating the reprogramming of energy metabolism upon 
activation (Supplementary Fig. 4f). Data correlation between mRNAseq and Ribo-Seq of 
only those metabolic genes that are differentially translated in LPS-activated HuR-cKO B 
cells showed that all of them, with the exception of dihydrolipoamide S-succinyltransferase 
(Dlst), were modestly increased (Fig. 4a and Supplementary Fig. 4g, 4h and 4j). Dlst mRNA 
was increased in GC B cells when compared to naive B cells (Supplementary Fig. 4i), but its 
mRNA expression and translation was significantly reduced in LPS-activated HuR-cKO B 
cells (Fig. 4b).
Dlst is one of the three subunits of the αKGDH enzymatic complex, which is essential for 
maintaining tricarboxylic acid (TCA) cycle flux and cell energy supply. In order to 
understand the role of HuR in Dlst mRNA regulation, we examined mRNAseq data and 
plotted the reads mapped across the Dlst locus as Sashimi plots (Fig. 4c). These mRNA 
splicing profiles showed that a single mRNA transcript was generated after RNA splicing in 
ex vivo and LPS-activated control B cells. In the absence of HuR, Dlst mRNA showed two 
alternative splicing events: intron 10 retention and alternative inclusion of a cryptic exon 
between exon 10 and 11. iCLIP data showed that HuR binds to several locations along Dlst 
Diaz-Muñoz et al. Page 5
Nat Immunol. Author manuscript; available in PMC 2015 October 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
RNA (Fig. 4c and Supplementary Fig. 5a-c). Peak calling analysis showed that HuR binds 
preferentially to introns, including the poly-pyrimidine tract found downstream the 3′ splice 
site of the cryptic exon present within intron 10 (Supplementary Fig. 5d). Taken together, 
these data demonstrate that HuR binding to Dlst pre-mRNA might promote Dlst mRNA 
expression and translation in HuR-cKO B cells. The modest change in translation of other 
components of cell energy pathways may reflect a compensatory mechanism.
HuR binding to introns modulates alternative intron usage
To gain a mechanistic insight into the role of HuR in mRNA splicing in B cells we further 
examined the HuR iCLIP data obtained from LPS-activated B cells. Analysis of unique read 
counts in all three iCLIP experiments showed that 75% of HuR-RNA crosslink sites were 
mapped to introns (Fig. 5a and Supplementary Fig. 5e and 5f). Visualisation of HuR 
crosslink sites close to the exon-intron boundaries indicated that HuR preferentially binds to 
introns, and showed a significant binding enrichment between the branch point and the 3′ 
splice site (Fig. 5b). These data suggested that HuR might be a splicing regulator in B cells, 
thus we studied whether HuR modulates pre-mRNA splicing by further analysis of 
mRNAseq data from LPS-activated B cells. Differential exon analysis using DEXSeq did 
not reveal significant changes in exon usage of protein coding transcripts in the absence of 
HuR, and failed to identify the alternative splicing events associated with Dlst mRNA 
(Supplementary Tables 1-5). Thus, we performed an intron-centric analysis of the mRNAseq 
data (Supplementary Fig. 6a), which showed that 530 introns belonging to 375 genes were 
differentially used in LPS-activated HuR-cKO B cells compared to control B cells 
(padj<0.1, Supplementary Fig. 6b). HuR was bound to 85% of these 375 genes in, at least, 
two of the three independent HuR iCLIP experiments (Fig. 5c). Dlst was found amongst 
these genes. Taken together data correlation from the intron-centric analysis and HuR iCLIP 
experiments identifies alternative intron usage in the absence of HuR.
HuR modulates mRNA expression and translation via splicing
Expression and translation analysis of all 375 genes with differential intron usage in HuR-
cKO B cells (group 1) showed no differences globally (Supplementary Fig. 6c). 
Individually, 64 genes (group 2) out of these 375 were differentially expressed in LPS-
activated HuR-cKO B cells and bound to HuR (Fig. 5d). A similar data correlation showed 
that 71 out of the 375 genes (group 3) were both differentially translated and bound to HuR 
(Fig. 5e). Only 25 of these genes (group 4) were both differentially expressed and translated 
in HuR-cKO B cells (Fig. 5f). When expression of genes in groups 1, 2 and 3 was analysed 
globally, no changes in mRNA abundance was observed when comparing HuR-cKO versus 
control B cells (Fig. 5g). By contrast, global translation of these mRNAs was significantly 
reduced in HuR-cKO B cells, suggesting that, even though HuR-dependent regulation of 
alternative splicing might not necessarily affect overall mRNA levels, HuR is required for 
mRNA translation (Fig. 5h). Global mRNA expression and translation of the genes in group 
4 were both reduced by up to 50%. Closer examination at individual genes indicated that 
both mRNA expression and translation of 76% of genes in group 4 (19 out of 25) were 
reduced in the absence of HuR, including Dlst (Fig. 5i and 5j). In summary, differential 
intron usage analysis and its correlation with differential expression in mRNAseq and Ribo-
Seq allowed us to discover the alternative intron events associated with HuR binding. 
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Visualization of the read coverage revealed high complexity in mRNA splicing associated 
with these genes, detecting up to 8 different alternative splicing events associated with the 
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 
(Slc25a19) in the absence of HuR (Supplementary Fig. 6d and 6e). Genetic deletion of either 
Dlst or Slc25a19 has been previously associated with reduced αKGDH enzymatic activity 
and alterations in the TCA cycle23, 24.
HuR regulates Dlst mRNA splicing
To understand the role of HuR in mRNA splicing, we selected Dlst mRNA for detailed 
analysis and evaluated usage of intron 10 with two RT-PCR assays. HuR-cKO B cells 
showed increased intron retention compared to control B cells (Fig. 6a). Read coverage 
analysis of the Dlst gene locus using mRNAseq data from HuR-cKO B cells identified a 
novel alternative exon splicing event located after exon 10. This alternative exon 10b was 
previously annotated in Ensembl as the start exon of predicted transcript 
ENSMUST00000165575, a transcript for which evidence of its existence is lacking. 
Detection of reads mapped across the exon 10/alternative exon 10b junction suggested that 
this was an alternative exon inclusion rather than an alternative first exon. RT-PCR 
validated this observation and indicated that over 50% of Dlst transcripts within HuR-cKO 
B cells included the alternatively spliced exon 10b (Fig. 6b). mRNAseq data showed little 
difference in Dlst mRNA expression between ex vivo or LPS-activated HuR-cKO and 
control B cells (Fig. 6c). However, the number of ribosome footprints mapped to Dlst 
mRNA was reduced by 2-fold in HuR-cKO B cells, indicating reduced mRNA translation 
(Fig. 6d). Visualization of ribosome footprints as Sashimi plots failed to identify ribosome-
protected reads mapped to the alternative exon 10b, suggesting that transcripts containing 
this exon were not translated (Supplementary Fig. 7a). Consistent with this, inclusion of 
alternative exon 10b introduces several stop codons into the coding sequence 
(Supplementary Fig. 7b). Immunoblot analysis of B cell protein extracts from ex vivo and 
LPS activated B cells confirmed a 50% reduction in Dlst protein abundance in HuR-
deficient B cells (Fig. 6e and 6f). Antibodies reactive with the N-terminus of Dlst could not 
detect any alternative protein isoforms produced as a consequence of exon 10b insertion in 
the absence of HuR (Supplementary Fig. 7c). Decreased Dlst protein expression was 
associated with a reduction in αKGDH enzymatic activity in HuR-cKO B cells (Fig. 6g). 
Taken together, HuR binding to Dlst intron 10 prevented alternative exon inclusion, thus 
guaranteeing Dlst mRNA translation into enzymatically active protein.
αKGDH is required for B cell proliferation and Ig CSR
Dlst, as part of the αKGDH complex, is highly regulated in order to maintain the flux 
through the TCA cycle. Inhibition of the αKGDH enzymatic activity using αKG analogs 
(succinyl phosphonate (SP) and phosphonoethyl ester of succinyl phosphonate (PESP)) 
significantly reduced B cell viability (Fig. 7a). Analysis of B cell proliferation following 
LPS + IL-4 stimulation showed that αKGDH inhibition reduced proliferation in a dose-
dependent manner (Fig. 7b and 7c). Further analysis of CSR showed that the number of 
IgG1+ cells was significantly reduced both after chemical inhibition of αKGDH enzymatic 
activity or in B cells with a single copy of the Dlst gene (Dlst+/− B cells) (Fig. 7d and 7e). 
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Thus, αKGDH enzymatic activity is required for in vitro B cell survival, proliferation and 
CSR.
ROS scavengers rescue B cell proliferation and Ig CSR
Analysis of HuR-cKO B cell cultures showed that cell viability was reduced in the absence 
of HuR (Fig. 8a and 8b). Viability of HuR-cKO B cells could not be rescued by blocking 
caspase-dependent apoptosis or programed necrosis using Q-VD-OPh or necrostatin-1 
respectively, but was reversed by the H2O2 scavenger catalase (Fig. 8b and c). Consistent 
with this, the fluorescence of the ROS reporter dye H2DCFDA showed that viable HuR-
cKO B cells produced larger amounts of ROS compared to Mb1-Cre+ controls. Addition of 
catalase reduced H2DCFDA fluorescence, indicating diminished ROS concentration (Fig. 
8b).
HuR-cKO B cells failed to proliferate when cultured with mitogens in vitro. Media 
supplementation with catalase as well as with ROS scavengers like sodium pyruvate, N-
acetyl cysteine and EUK134 enhanced the proliferation of HuR-cKO B cells in response to a 
variety of stimuli (Fig. 8d and supplementary Fig. 8). Quantitation of the number of B cells 
recovered showed that HuR-cKO B cells undergo a similar number of cell divisions; 
however the number of cells in each division was reduced, indicating that ROS scavengers 
did not completely restore proliferation (Fig. 8e). ROS scavengers led to a recovery in the 
percentage and number of IgG1+ and CD138+ (ASC) HuR-cKO B cells (Fig. 8f and 8g). 
However NAC and EUK134 marginally inhibited the yield of IgG1+ and CD138+ cells in 
control cultures. Taken together, our data indicate that HuR-cKO B cells contained elevated 
amounts of ROS and these compromised B cell survival. Mitigating ROS allowed the HuR-
cKO B cells to proliferate, undergo CSR and form ASC in vitro.
DISCUSSION
Here we show that HuR is dispensable for B cell development, but that the GC response and 
the production of class-switched antibodies following immunisation with T-independent 
antigens are highly dependent upon HuR. Our in vitro experiments indicate that HuR may 
control B cell metabolism upon activation to limit ROS production, but further validation in 
the context of the GC response is required.
The regulation of intracellular ROS is important during lymphocyte activation25. Increased 
ROS are found in activated B cells taken from virally infected mice26. B cells defective in 
HVCN1 make less ROS and have attenuated antibody responses27, and antioxidant 
administration to mice increased B cell apoptosis and decreased proliferation26. However, 
lack of ROS production in gp91 deficient mice has been linked to modestly increased 
responses to TI-2 antigens28. Thus a general picture is emerging in B cells in which ROS 
production can be separated in space and time. Low levels of ROS have mitogenic 
properties whereas high levels will induce cell death29, 30. H2O2 produced by NAPDH 
oxidases after BCR crosslinking exerts a short-lived function as inhibitor of protein tyrosine 
and lipid phosphatases31, thus enhancing signal transduction. BCR-associated ROS 
production early after antigen encounter may not be essential for B cell proliferation, 
however, mitochondrial-mediated ROS production is required to sustain BCR-mediated 
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activation28, 32. Interestingly, in vitro exposure to H2O2 can revive signalling by the BCR on 
GC B cells33. The mechanism proposed by Wheeler et al. involves enhancement of the 
PI3K-mTORC axis for metabolic reprogramming after lymphocyte activation34,35. Our 
global transcriptome analysis, comparing naive versus GC B cells and ex vivo versus LPS-
stimulated B cells, reinforces previous observations that both glycolysis and oxidative 
phosphorylation are increased after B cell activation2, 36, as part of a metabolic program 
taking place both in GC B cells 37 and in vitro stimulated B cells to promote survival and 
proliferation, and in which post-transcriptional regulation by HuR is a critical component.
The presence of hydroxyl radicals also enhances deamination of cytosine to uracil, a 
reaction that is necessary for CSR38. CSR requires control of ROS levels by DNA damage 
sensing proteins such as p53 and Atm. P53 limits ROS production in B cells and promotes 
switching to IgG2a39. Atm expression during DSB decreases ROS levels via regulation of 
cell energy pathways. Atm−/− mice have an impaired antibody response and elevated ROS 
that is restored by treatment with NAC40. Furthermore, the Atm-specific inhibitor 
KU-55933 decreases cellular ATP levels by reducing TCA cycle intermediates and 
oxidative respiration41. Thus we suggest that reduced energy metabolism during CSR may 
limit cell cycle progression and prevent the accumulation of ROS until DSB are repaired. By 
sustaining the TCA cycle, HuR ensures provision of the reducing equivalents required for 
ATP synthesis and/or ROS scavenging.
Evidence has accumulated to demonstrate increased glycolysis is part of a metabolic switch 
during activation of immune cells1. Although the TCA cycle is the main provider of 
reducing equivalents for oxidative phosphorylation, its regulation remains largely 
unexplored during lymphocyte activation. We have used CPI-613 to inhibit PDH and 
αKGDH, two key enzymes of the TCA cycle, resulting in a block in B cell growth and 
proliferation. Recently, it has been reported that CPI-613 induces an oxidative burst 
responsible for αKGDH enzymatic activity inhibition42. This observation underscores the 
importance of regulating ROS production during B cell activation and is strengthened by our 
finding that phosphonate analogues of αKG43 reduce B cell viability and proliferation. The 
number of IgG1+ cells recovered after in vitro B cell activation in the presence of 10 mM 
PESP is reduced by five-fold even though cell proliferation is less affected, being consistent 
with our results from Dlst+/− B cells, suggesting that B cells undergoing CSR are more 
susceptible to ROS.
Notably, Dlst+/− B cells do not recapitulate the in vitro phenotype of HuR-cKO B cells. This 
likely reflects as yet unidentified roles for other targets of the HuR-splicing program that are 
important during B cell activation. Amongst the 375 genes identified as HuR dependent is 
Slc25a19 depletion of which also reduces αKGDH enzymatic activity23.
The αKGDH complex has three subunits: α-oxoglutarate dehydrogenase (Ogdh), 
dihydrolipoamide S-succinyltransferase (Dlst), and dihydrolipoamide dehydrogenase (Dld). 
Dlst is a haploinsufficient gene and heterozygote mice show increased ROS production and 
cell death in the brain44. The APP670/671 mutation of Dlst in humans reduced enzyme 
activity and causes Alzheimer’s disease associated with mitochondrial dysfunction and cell 
death45. Decreased Dlst diminishes the provision of reducing equivalents and succinyl-CoA 
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required for GTP synthesis by matrix substrate-level phosphorylation46. Increased ROS 
levels in the absence of HuR may be due increased mRNA translation of genes of the 
oxidative respiratory chain, but reduced matrix substrate-level phosphorylation may 
additionally contribute to ROS production by increasing ADP levels47. Furthermore, 
αKGDH activity generates •O2− which acts as a negative regulator of αKGDH enzymatic 
activity48, 49. Thus, oxidative stress may promote cell death due to inhibition of flux through 
the TCA cycle50.
Our novel approach of integrating global analysis of mRNA expression and translation 
comparing control and HuR-cKO primary B cells reveals a role for HuR in the regulation of 
the metabolism after B cell activation. We have applied a novel bioinformatics approach to 
identify differential intron usage based on read counting within intron bins defined as 
windows between annotated exons. We have identified 530 introns from 375 genes that are 
differentially expressed in the absence of HuR. HuR loss is associated with aberrant intron 
inclusion which compromises, in case of Dlst, mRNA abundance and translation, but may 
also affect the isoform of translated proteins. A quantitative analysis of full length 
transcripts and alternative protein isoforms in the presence and absence of HuR should 
address this. We suggest that HuR, like other splicing regulators, promotes the correct 
splicing of pre-mRNA and provides a quality control mechanism for the transcriptome. In 
the context of B cell activation, HuR depletion promotes an imbalance in energy metabolism 
that leads to the fatal accumulation of ROS and impairs B cell proliferation and CSR.
ONLINE METHODS
Reagents, antibodies and oligonucleotides
Information is detailed in Supplementary Table 6, 7 and 8.
Mouse strains and animal procedures
Mice on the C57BL/6 background used in this study are: CD79atm1(cre)Reth 51 and 
Elavl1tm1Dkon 16. Dlst+/− mice were generated by Lexicon Pharmaceuticals, Inc. (The 
Woodlands, Texas)24. Immunisations were performed by intraperitoneal administration of 
Sheep Red Blood Cells (SRBCs, 2 × 108 cells/mouse), NP-Ficoll (25 μg), NP-LPS (25 μg) 
or alum-precipitated NP-KLH (100 μg). For in vivo experiments, the number of animals was 
decided based on preliminary studies using small cohorts to assess the magnitude of the 
changes (2-3 mice per genotype). 6 to 10 mice (12-16 weeks old) were considered a 
sufficient number of mice in final studies to reach sufficient statistical power analysis. No 
animals were excluded due to a lack of responsiveness to immunisation. Randomization, but 
not experimental blinding, was performed in these studies. All animal procedures at the 
Babraham Institute were approved by the Babraham Institute AWEEC, the UK Home 
Office. Local Ethical Committee for Animal Experiments of KU Leuven, Belgium approved 
experimentation with Dlst+/− mice under license number 000/2014.
ELISA and ELISPOT assays
Serum immunoglobulins and NP-specific antibodies were detected by ELISA52. NP-specific 
antibody end point titers were used as a measure of relative concentration. NP-specific 
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antibody secreting B cells (ASC) were detected by ELISPOT assays performed as 
previously described9.
Flow cytometry
Analysis of B cell populations was performed using specific antibodies for cell surface 
markers. B cell population analysed in bone marrow were: Pre-Pro-B cells - B220lo IgM− 
CD25− c-kit+ CD19−; Pro-B cells - B220lo IgM− CD25− c-kit+; Pre-B cells - B220lo IgM− 
CD25+ CD19lo; immature-B cells - B220+ IgM+ IgD−; and mature-B cells - B220+ IgM+ 
IgD+. B cell subsets identified in spleen were: T1 - B220+ CD93− CD23− IgMhi; T2 - B220+ 
CD93− CD23+ IgMhi; T3 - B220+ CD93− CD23+ IgM+; MZ - B220+ CD93+ CD21hi 
CD23−, FO - B220+ CD93+ CD21+ CD23+ and GC B cells - B220+CD95+PNA+.
Fixable Viability Dye eFluor® 780 or DAPI was used to test cell viability. For intracellular 
staining of HuR, the BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution Kit was 
used. In vitro B cell proliferation was tested by flow cytometry after the labelling of ex vivo 
B cells with the CellTrace™ Violet dye. ROS levels in B cells were measured by using 
OxyBURST® Green H2DCFDA (1 μM) added into the B cell culture 30 min before cell 
analysis by flow cytometry.
Calcium flux analysis
Purified LN B cells were loaded with Fluo-4 AM (3 μM) in PBS + 0.5% BSA (5 × 106 
cells/ml) for 30 min at RT in the dark. After washing, cells were incubated in 0.5% 
BSA/PBS containing 1 mM CaCl2 for further 30 min to allow de-esterification of 
intracellular Fluo-4 AM ester. Changes in fluorescence emission (at 494 nm) after surface Ig 
crosslinking were measured using a PerkinElmer LS 55 Fluorescence spectrometer.
B cell isolation and cell culture
B cells from spleen or peripheral lymph nodes were isolated by using the B Cell Isolation 
Kit from Miltenyi Biotec. B cells were cultured in RPMI 1640 Medium (Dutch 
Modification) plus 5% FCS, antibiotics, 2 mM L-glutamine and β-mercaptoethanol (5 μM). 
ROS scavengers, Q-VD-OPh, Necrostatin-1 (Nec-1), 2-deoxy-glucose (2-DG), CPI-613, 
Oligomycin A, Succinyl phosphonate (SP) and Phosphonoethyl ester of succinyl 
phosphonate (PESP) were added to the cell culture media when indicated in the figure 
legend. Mitogen activation of B cells was carried out using either LPS (E.coli 0127:B8), 
αCD40 (3/23 clone) or αIgM (B7.6 clone) in the presence or not of IL4 and IL5.
Protein separation and Western Blot analysis
Total cell extracts were prepared by incubating cells in RIPA buffer (50 mM Tris-HCl, pH 
7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS and 0.5% Sodium deoxycholate) supplemented 
with protease inhibitors. 10% polyacrylamide-SDS gels were loaded with 20 μg of total 
protein extracts per lane. Gel electrophoresis and protein transfer to nitrocellulose 
membranes was performed prior detection of HuR, Dlst and β-actin by Western blot using 
specific antibodies and enhanced chemiluminescence or IRDye detection.
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RNA extraction and RT-PCR assays
Total RNA extraction from purified B cells was performed using TRIzol (LifeTech). 1 μg of 
RNA was treated with DNase I prior reverse transcription into cDNA. Analysis of Dlst 
alternative splicing events were performed by RT-PCR using specific primers (table S3). 
Intron retention was quantified by qPCR whereas alternative exon inclusion was quantified 
after gel densitometry of the PCR products. qPCR assays were performed using Platinum® 
SYBR® Green qPCR SuperMix (Life Technologies). mRNA expression of Dlst and Elavl 
genes was quantified by the ΔΔCT method (comparative threshold cycle) and normalised to 
the expression of 18S rRNA.
Immunofluorescence microscopy
Ex vivo or mitogen- activated splenic B cells were cultured for 20 minutes on cover slips 
coated with 0.01% Poly-L-Lysine prior detection of HuR by immunofluorescence 
microscopy as previously described53. Images from three independent experiments were 
captured with an Olympus FV1000 System and processed using Image-J.
Individual-nucleotide resolution Cross-Linking and ImmunoPrecipitation (iCLIP)
iCLIP experiments were performed as described 21, using protein lysates from splenic B 
cells activated with LPS for 48 hours (n=3). Briefly, splenic B cells were irradiated with 
UV- light to crosslink protein-RNA interactions (150 mJ/cm2, Stratalinker 2400). After 
washing cells with ice-cold PBS, total cell extracts were obtained using RIPA buffer and 
sonication (x3). Extract supernatants was treated with RNase I (0.167 U/ml) for 3 minutes at 
37°C. Immunoprecipitation of HuR-RNA complexes was performed using 2 μg. of αHuR 
mAb coupled to protein G dynabeads. B cell extracts from HuR-cKO B cells were used as a 
negative control. After washing twice with high-salt buffer (50 mM Tris-HCl pH 7.4, 1 M 
NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate) and once with 
PNK washing buffer (20 mM Tris-HCl pH 7.4, 10 mM MgCl2, 0.2% Tween-20), one tenth 
of the sample were labelled with 32P-ATP using PNK, whereas an RNA Linker was ligated 
to the rest of the sample after RNA dephosphorilation. RNA-protein complexes were 
separated by electrophoresis (SDS-Page) and transfer to nitrocellulose membranes. HuR-
RNA complexes higher than 55 KDa were marked after visualization by autoradiography. 
RNA extraction was performed by incubating the nitrocellulose fragment at 37°C for 10 
minutes with proteinase K in PK buffer (100 mM This-Cl pH 7.5, 50 mM NaCl and 10 mM 
EDTA). 200 μl of PK buffer containing urea (7 M) was added to each sample and further 
incubated at 37°C for 20 minutes. RNA was isolated by phenol/clorophorm extraction and 
ethanol precipitation. RNA was retro transcribed into cDNA using RCLIP primers and 
SuperScript III reverse transcriptase. After cDNA purification using 6% TBE-urea gels, 
cDNA was circularised and amplified by PCR using Solexa P5/P7 primers. cDNA libraries 
from three independent experiments were prepared and analysed. RCLIP primers included a 
7 bases long barcode at the 5′end (three known bases plus four unknown nucleotides). 
Additional two bases (AT) were added to the 3′end. Barcodes allowed us to multiplex 
different cDNA libraries for Illumina sequencing and identify PCR duplicate reads.
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High throughput sequencing and library preparation
mRNAseq libraries were obtained using TruSeq Stranded mRNA Sample Prep Kit (Illumina 
Inc). Splenic B cells from individual HuRf/f control or HuR-cKO mice were independently 
processed for RNA extraction (ex vivo samples, n=4 per genotype) or were stimulated with 
LPS for 48 hours in RPMI media plus 1 mM NaPyr (n=3-4 per genotype).
Previously published mRNAseq libraries were used to analyse the expression of genes 
involved in glycolysis, TCA cycle and electron transport in naive and GC B cells (GEO 
deposition number - GSE47705)54.
Ribosome footprinting profiling (Ribo-Seq) assays were performed using ARTseq™ 
Ribosome Profiling Kit (Epicentre, Illumina). Ex vivo or LPS-activated B cells (n=4-5 per 
genotype and condition) were treated with cyclohexamide (CHX, 100 μg/ml) three minutes 
prior cell extract preparation. cDNA libraries were sequenced using either GAIIX (iCLIP) or 
HTSeq2000 (mRNAseq and Ribo-Seq) Illumina technology. The type of sequencing 
performed was: iCLIP, 40 bp SE; mRNAseq, 100 bp SE; and Ribo-seq, 50 bp SE.
Bioinformatics and statistics
Mapping and peak call analysis of HuR iCLIP data was performed as described 
previously 21. Briefly, RCLIP primers were used to generate the cDNA libraries from HuR 
iCLIP experiments. Data demultiplexing involved identification of the three known bases of 
the 5′ barcode. Quality analysis of sequencing data was done using FastQC. Data analysis 
was done in the iCount pipeline. First, the four unknown bases of the 5′ barcode were used 
to remove PCR duplicate reads. 3′ barcode (AT) was used to define the length of the reads. 
Both parameters were important to identify unique reads. Then, reads were trimmed to 
remove 5′ and 3′ barcodes along with any adaptor sequence before mapping to the genome 
using Bowtie. Data was originally annotated to mm9 genome, but was lifted over to mm10 
genome using Galaxy. Once genome annotation was completed, nucleotide −1 was located 
and used for data visualization in UCSC genome viewer. This base is the HuR- crosslink 
binding site. The number cDNA counts associated to a single HuR- crosslink site was 
quantified base on read length and unique 5′ barcode sequence. Peak call analysis was 
performed to identify unique HuR-crosslink binding sites with a FDR<0.05. Peak call 
analysis was performed in iCount by genome wide analysis of 30 base windows defined 
after annotation at single nucleotide resolution of HuR-RNA interactions (15 nucleotides 
flanking a cross link site). Peak enrichment analysis and FDR calculation was performed 
allowing 100 permutations and multiple hypothesis testing to correct for multiple 
comparisons.
Raw sequencing data from mRNAseq and Ribo-Seq was demultiplexed, FastQ analysed and 
mapped to mm10 genome annotation using Tophat. Differential gene expression analysis of 
mRNAseq and Ribo-Seq datasets was performed using DESeq and DESeq2 packages55. 
Briefly, data was adjusted to a negative binomial distribution after correction by library size 
factor. Differential expression analysis, p value determination and Benjamini-Hochberg 
multiple test correction of the p values were performed to obtain final padj values. DEXSeq 
package was used for exon and intron usage analysis56. First, we define exons and introns 
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by using the Ensembl exon annotation for protein coding transcripts (GRCm38.72) and we 
independently counted reads within the exon and intron bins by using HTSeq. Read 
counting along exon bins was required in order to estimate the library size factors. We then 
used these size factors to normalise the intron bins and assessed differential intron usage 
with DEXSeq. A hypergeometric statistical test followed by Benjamini-Hochberg correction 
of the p- values was performed for pathway enrichment analysis57, 58. UCSC and IGV were 
used to visualise read coverage (see Supplemental Information). Sequencing data was 
visualised in UCSC genome viewer. Read coverage of mRNAseq and Ribo-Seq data was 
visualised in the Integrated Genome Browser (IGV).
Unpaired t tests or Mann-Whitney tests were performed for statistical analysis of non-
sequencing data. More details about sample size and the statistical test performed in each 
experiment are indicated in each figure legends.
Data deposition
High throughput sequencing data was deposited in Gene Expression Omnibus (GEO). 
Identification numbers are: GSE62129 for mRNAseq, GSE62134 for Ribo-seq and 
GSE62148 for iCLIP.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. HuR expression is increased during B cell activation
(a) qPCR analysis of Elavl1 (HuR), Elavl2, Elavl3 and Elavl4 mRNA expression in ex vivo 
splenic B cells (n=6) and brain (n=2). Data shown relative to Elavl1 mRNA expression (ND 
= not detected). (b) Intracellular HuR staining in B cell subsets in the bone marrow (BM). 
(c) HuR protein expression in splenic B cell subsets. B cell populations in BM and spleen in 
Mb1-Cre (unfloxed controls, Ctrl.) and Elavl1fl/flMb1-Cre (HuR-cKO) mice were analysed 
by flow cytometry as described in online methods. (d) Quantification of HuR expression. 
Median Fluorescence Intensity (MFI) of HuR staining relative to an isotype control (IC) 
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antibody is shown (n=3 biological replicates). Dashed line indicates the detection limit of 
the assay. (e) Normalised HuR mRNA expression in GC B cells (B220+CD95+PNA+) 
relative to the expression of HuR mRNA in non-GC B cells (B220+PNA−CD95−). A 
representative dot plot is shown to indicate cell sorting strategy. Cells from individual mice 
were isolated independently for mRNA expression analysis. Data from each individual 
sample and the mean value are shown (n=3-4 per group, unpaired t-test). (f) HuR protein 
expression in non-GC and GC B cells from individual immunised mice measured by flow 
cytometry. Data from each individual sample and the mean value are shown. (n=6, unpaired 
t-test). Histograms and dot plots shown in b, c, e and f are representative of more than 3 
independent stainings using individual mice. (g) Time course analysis of HuR expression 
after in vitro B cell activation with LPS or αCD40+IL-4+IL-5. Immunoblots are 
representative of four (activation with LPS) or two (activation with αCD40+IL-4+IL-5) 
independent experiments respectively. In each experiment, HuR (Abs794) expression was 
normalised by β-actin levels and quantified relative to non-activated B cells. Data is shown 
as mean value.
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Figure 2. HuR-cKO mice have no major defects in B cell development
(a) Analysis of B cell populations in the bone marrow of Mb1-Cre (Ctrl) and Elavl1fl/flMb1-
Cre (HuR-cKO) mice. Representative dot plots summarise the cell gating strategy and cell 
frequency. The number of Pre-, immature-, and mature-B cells was calculated based on the 
expression of surface cell markers. (b) Quantitation of the number of different B cell subsets 
in the spleen of Ctrl. and HuR-cKO mice. T1, T2, T3, FO and MZ B cells were defined 
based on cell surface markers as described in the online methods. (c) Analysis of the number 
of CD19+ cells in peripheral lymph nodes. (d) Analysis of B1 B cells in the peritoneal 
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cavity. Representative dot plots summarise the cell gating strategy and cell frequency. 
Analysed data shown in a, b, c and d are from individual mice of each genotype and is 
representative of more than 3 independent experiments (n=8 per group; Mann-Whitney 
analysis was performed; *p<0.05, **p<0.005, ***p<0.0005). (e) Representative flow 
cytometry plots of BrdU incorporation in Pre-B cells after 2.5 hours labelling. The mean 
percentage ± SD of BrdU+ cells is shown (n=8 per group). (f) Analysis of BrdU+ mature B 
cells following 7 days labelling. Representative dot plots and contour plots are shown. The 
mean percentage ± SD of BrdU+ cells is shown (n=5 individual mice per group).
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Figure 3. B cells require HuR for responses to different classes of antigens
(a) Quantitation of serum immunoglobulin in non-immunised mice. Samples from 
individual Mb1-Cre (Ctrl) and Elavl1fl/flMb1-Cre (HuR-cKO) mice were collected in two 
independent experiments (n=10; Mann-Whitney test). (b, c) Analysis of NP-reactive IgM 
and IgG3 antibodies present in serum samples from individual mice of each genotype 
collected 7 days after immunization with NP-LPS (b) or NP-Ficoll (c). Dot line indicates the 
limit of detection in this assay (n=6 per group in b; n=6-7 per group in c; Mann-Whitney 
test). (d) Time course analysis of NP23 reactive IgM and IgG1 in serum of mice immunised 
with NP-KLH at day 0 and day 42. (e) Ratio of NP2- bound (high affinity) and NP23-bound 
(low + high affinity) IgG1 antibodies. Data is shown in d and e as mean ± SEM, n=6/group. 
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Statistical analysis of the data at each time point was performed using a Mann-Whitney test 
(p<0.005 in all cases). (f) The number of GC B cells present in the spleen of Mb1-Cre (Ctrl) 
and HuR-cKO mice seven days after immunization with NP-KLH. Representative dot plots 
show the gating strategy and frequency of GC B cells (B220+ PNA+ CD95+ cells). The 
number of GC cells in individual mice of each genotype (n= 7-8 mice) from one of the two 
independent experiments performed is shown (Mann-Whitney test). (g) ELISPOT of the 
number of IgM and IgG1 ASC present in the spleens of the mice analysed in f (n=7-8, 
Mann-Whitney test). (h, i) Quantitation of IgM-ASC and IgG1-ASC present in spleen (h) 
and BM (i) of Mb1-Cre (Ctrl.) and HuR-cKOmice seven days after secondary immunization. 
Data from each individual mice of each group is shown (n=7-8; Mann-Whitney test) 
(*p<0.05, **p<0.005, ***p<0.0005).
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Figure 4. Genes involved in energy metabolism are deregulated in HuR-deficient B cells
(a) Analysis of the fold change in mRNA expression and mRNA translation (HuR-cKO/
Ctrl) of those genes involved in cell energy pathways (Glycolysis and Gluconeogenesis, 
TCA Cycle and Electron Transport Chain) that are differentially translated in the absence of 
HuR (number of genes=25). mRNAseq and Ribo-seq libraries were generated in two 
independent experiments using LPS-activated splenic B cells from Elavl1fl/flMb1+/+ (Ctrl) 
and Elavl1fl/flMb1-Cre (HuR-cKO) mice (RNAseq, n=3-4 per group; Ribo-seq, n=5 per 
group). (b) Statistical significance of changes in mRNA expression and translation of the 
genes shown in a. P adjusted values (padj) were calculated after multiple correction of p 
values (Benjamini-Hochberg correction) obtained from DESeq analysis of RNAseq and 
Ribo-seq datasets. (c) Dlst mRNA splicing profiles in Ctrl and HuR-cKO B cells. 
Representative sashimi plots were generated in IGV. The exon number and read counts 
across each exon-exon junction are indicated for representative mRNAseq data from ex vivo 
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and mitogen activated B cells. HuR iCLIP data for the Dlst locus collected from three 
independent experiments is shown as unique single nucleotide crosslink sites.
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Figure 5. HuR regulates intron usage in B cells
(a) Proportion of unique HuR crosslink sites annotated to each genomic features. The sum of 
unique cDNA counts from three independent iCLIP experiments performed with LPS-
activated B cells (Supplementary Fig. 5) was used for peak call analysis (FDR<0.05) and 
quantification of HuR crosslink sites. (b) RNA map of crosslink sites assessed at the exon-
intron boundaries (BP=branch point; 5′ SS=5′ splice site; 3′ SS=3′ splice site). (c) 
Correlation between HuR binding and differential intron expression in HuR-cKO B cells. 
(d) Venn-diagram showing the relationship between genes with differential intron 
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expression (Genes), differential mRNA expression (mRNAs) and mRNA bound by HuR 
(Targets). (e) Relationship between genes with differential intron expression (Genes), 
differential ribosome occupancy (mRNAs) and HuR binding (Targets). (f) Identification of 
mRNAs with differential intron expression which are both differentially expressed and 
differentially translated. (g) Global analysis of the fold change (HuR-cKO/Ctrl) (log2) in 
mRNA expression of all genes; genes with differential intron expression (group 1; n=375); 
HuR-targeted genes with differential intron usage and differential RNA abundance (group 2; 
n=64); HuR-targeted genes with differential intron usage and differential ribosome 
occupancy (group 3; n=71); and HuR-targeted genes with differential intron expression 
which are both differentially expressed and differentially translated (group 4; n=25). (h) 
Global analysis of the fold change (HuR-cKO/Ctrl) (log2) in ribosome occupancy in the 
groups described in g. Data in g and h is shown as box whisker plots showing the mean ± 
SD and 10-90 percentiles. Wilcoxon signed-rank test was performed between each group 
against all genes (* p<0.05, ** p<0.005). (i) Heatmap of the fold change (HuR-cKO/Ctrl) 
(log2) in mRNA expression of genes in group 4. (j) Heatmap showing the fold change 
(HuR-cKO/Ctrl) (log2) in ribosome occupancy of genes in group 4. Genes previously 
annotated as alternative spliced are highlighted in blue.
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Figure 6. Alternative splicing of Dlst in HuR-cKO B cells reduces αKGDH enzymatic activity
(a) Design summary of PCR primers, spanning exon 10/intron 10 junction and intron 10/
exon 11 junction, used to detect intron inclusion in Elavl1fl/flMb1-Cre (HuR-cKO) B cells. 
Intron inclusion in ex vivo and LPS-activated B cells was quantified relative to 
Elavl1fl/flMb1+/+ (Ctrl) cells. (b) PCR across the exon 10/exon 11 junction. The percentage 
of alternative exon inclusion was calculated after gel density quantification of long 
(alternative exon included) and short (alternative exon skipped) amplicons. Data in a and b 
was from 6 (naïve cells) or 4 (LPS-treated cells) biological replicates collected in two 
independent experiments and is shown as mean values ± SD (unpaired t test; * p<0.05, *** 
p<0.0005). Images are representative. (c) Dlst reads measured by mRNAseq in ex vivo and 
LPS-activated B cells from Ctrl and HuR-cKO mice. Mean normalised read counts ± SD are 
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shown (n=3-4 per group; differential expression analysis performed with DESeq; 
*padj<0.05, ***padj < 0.0005). (d) Quantification of ribosome footprints mapped to Dlst 
mRNA. Data from ex vivo and LPS-activated B cells is shown as mean normalised read 
counts ± SD (n=4-5 per group; differential expression analysis performed using DESeq2; 
***padj < 0.0005). (e) Immunoblot analysis of Dlst protein. Total protein lysates were 
prepared from ex vivo and LPS-activated splenic B cells from Elval1fl/flMb1+/+ (Ctrl) and 
HuR-cKO mice in three independent experiments and loaded in the same gel. β-actin was 
detected as sample loading control. (f) Gel density quantification of Dlst protein abundance 
relative to β-actin (n=3 per group; unpaired t test; *p<0.05). (g) αKGDH enzymatic activity 
in total cell extracts from ex vivo B cells collected from individual Elavl1fl/flMb1+/+ (Ctrl.) 
and HuR-cKO mice (Mean ± SD; n=4 per group from two independent experiments; 
unpaired t test; *p<0.05).
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Figure 7. αKGDH enzymatic activity is required for B cell survival and proliferation
(a) Viability of splenic B cells activated with LPS + IL-4 (96 h) in the presence of the 
indicated doses of succinyl phosphonate (SP) or phosphonoethyl ester of succinyl 
phosphonate (PESP). Data from one of the two independent experiments performed is 
shown as mean ± SD (n=4 per group; unpaired t tests comparing control samples against 
each different dose; *p<0.05, **p<0.01, ***p<0.001). (b) Representative CellTrace™ Violet 
(CTV) dye profiles in the presence of SP and PESP. The number of cells in each generation 
was calculated based on dye dilution. (c) In vitro proliferation of Dlst+/+ and Dlst+/− splenic 
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B cells after activation with LPS + IL-4 for 96 hours analysed by CellTrace™ Violet dye 
dilution as described in b. Splenic B cells were isolated from 6 different mice and treated 
separately in two independent experiments. Data are shown as the mean number of cells per 
generation ± SD. Two way ANOVA test was performed (p=0.0162). (d) Quantification of 
the number of IgG1+ cells in cultures described in c. Representative plots show CellTrace™ 
Violet dye dilution versus IgG1 surface expression. Unpaired Student’s t test was performed 
for statistical analysis of the data (n=6; *p<0.05). (e) Analysis of CSR in the cultures in a. 
Representative plots and the mean number of IgG1+ cells ± SD from one of the two 
independent experiments are shown (n=4 per group; unpaired Student’s t test comparing no 
treated cells against the other conditions; *p<0.05, **p<0.01, ***p<0.001).
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Figure 8. ROS scavengers rescue HuR-deficient B cells from cell death
(a) Representative plots showing H2DCFDA and DAPI staining of Mb1-Cre (Ctrl) and 
HuR-cKO B cells after four hours of in vitro culture in the absence or presence of 
recombinant catalase (Cat, 20 U/ml). (b) Quantitation of the number of DAPI+ cells and the 
MFI of H2DCFDA in DAPI− cells in the cultures described in a (Mean ± SD, n=3 per 
group). (c) Effect of Q-VD-OPh (3 μM) and Necrostatin-1 (Nec-1, 3 μM) on in vitro B cell 
survival (Mean number of DAPI− cells ± SD, n=4 per group). (d) Representative 
CellTrace™ Violet dye profiles of LPS + IL-4 stimulated Mb1-Cre (Ctrl.) and HuR-cKO B 
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cells cultured in complete RPMI media supplemented with catalase (20 U/ml), L-N-acetyl-
cysteine (L-NAC, 10 mM) or EUK-134 (5 μM) for 96 hours. (e) Number of live cells in 
each cell generation of the proliferation profile shown in d (Mean ± SD, n=3 per group). (f) 
Representative plots and the mean number of IgG1+ cells ± SD. (g) Representative plots and 
the mean number of CD138+ cells ± SD is shown. Data shown in each figure panel is from 
one of the at least three independent experiments performed. Unpaired Student’s t tests were 
performed for statistical analysis of the data (*p<0.05,**p<0.01,***p<0.001).
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Table 1
Pathway enrichment analysis
Gene ontology analysis of Ribo-seq data from LPS-activated B cells performed using WebGestalt pathway 
enrichment analysis. The number of total and differentially expressed (DE) genes in HuR-cKO B cells 
compared to control (Ctrl) B cells is indicated. Gene sets contained a minimum of 6 genes and a 
hypergeometric test and multiple test correction (Benjamini-Hochberg) of p values was performed during the 
statistical analysis.
Pathway Name Total genes DE genes padj value
mRNA processing 456 58 5.98*10−14
miRNA regulation of DNA Damage Response 69 14 6.54*10−06
G1 to S cell cycle control 65 12 8.63*10−05
Senescence and Autophagy 109 15 2.00*10−04
Apoptosis 93 13 5.00*10−04
Androgen Receptor Signaling Pathway 123 15 6.00*10−04
Cytoplasmic Ribosomal Proteins 78 11 1.20*10−03
B Cell Receptor Signaling Pathway 200 19 1.60*10−03
Electron Transport Chain 101 12 2.40*10−03
Glycolysis and Gluconeogenesis 50 8 2.60*10−03
DNA Replication 41 7 3.20*10−03
PluriNetWork 289 23 3.20*10−03
IL-5 Signaling Pathway 80 10 3.30*10−03
TCA Cycle 32 6 3.70*10−03
T Cell Receptor Signaling Pathway 143 14 3.70*10−03
Adipogenesis 133 13 5.10*10−03
Alzheimers Disease 77 9 6.50*10−03
Toll Like Receptor signaling 37 6 6.50*10−03
Cell cycle 95 10 8.10*10−03
Amino Acid metabolism 112 11 8.40*10−03
MAPK signaling pathway 165 14 9.60*10−03
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